These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5307101)

  • 21. Specific sequestering agents for the actinides. 4. Removal of 238Pu(IV) from mice by sulfonated tetrameric catechoyl amides.
    Durbin PW; Jones ES; Raymond KN; Weitl FL
    Radiat Res; 1980 Feb; 81(2):170-87. PubMed ID: 6444746
    [No Abstract]   [Full Text] [Related]  

  • 22. Removal of firmly bound promethium from the rat. BNWL-1050.
    Smith VH
    BNWL Rep; 1970 Jan; ():5.3+. PubMed ID: 5311297
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
    Osenthal MW; Lindenbaum A
    Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
    [No Abstract]   [Full Text] [Related]  

  • 24. [Complexons in the treatment of lupus erythematosus].
    Glavinskaia TA; Grube SB; Pavlova LT; Shutov AN
    Vestn Dermatol Venerol; 1980 Dec; (12):24-8. PubMed ID: 7010826
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic and therapeutic studies of plutonium. IV. ANL-7535.
    Lindenbaum A; Rosenthal MW; Lund CJ; Russell JJ; Smoler MH; Moretti ES; Brown H
    ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficiency of low level DTPA therapy in removing plutonium from mice.
    Smith H; Chapman IV; Marlow CG
    Nature; 1969 May; 222(5194):676. PubMed ID: 5768280
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the efficiency of DTPA and other new chelating agents for removing neptunium from target organs.
    Paquet F; Metivier H; Poncy JL; Burgada R; Bailly T
    Int J Radiat Biol; 1997 May; 71(5):613-21. PubMed ID: 9191906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of 143Pm in a minature swine. BNWL-714.
    Smith VH; Amster RL; Watson CR
    BNWL Rep; 1968 May; ():5.20-5+. PubMed ID: 5307092
    [No Abstract]   [Full Text] [Related]  

  • 29. [241Am body distribution in dogs after its intravenous administration and early complexon therapy].
    Sokhranich AL; Liubchanskiĭ ER
    Med Radiol (Mosk); 1990 Jan; 35(1):39-41. PubMed ID: 2308499
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigations into techniques for removing intracellular plutonium--II. Complexing agents bound to macromolecules.
    Bulman RA; Griffin RJ
    Health Phys; 1981 Feb; 40(2):228-31. PubMed ID: 6163749
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of various complex-breaking substances including chelators as potential anti-plaque agents.
    Saimbi CS; Upadhayaya V; Singh C; Kapoor KK; Chawla TN; George PA
    J Indian Dent Assoc; 1982 Nov; 54(11):409-14, 417. PubMed ID: 6962242
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative assessment of the toxic action of cerium-144 and promethium-147 in rats according to biochemical indices].
    Fedorova AV; Zapol'skaia NA
    Radiobiologiia; 1977; 17(2):221-5. PubMed ID: 882647
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic removal of internally deposited transuranium elements.
    Smith VH
    Health Phys; 1972 Jun; 22(6):765-78. PubMed ID: 5084009
    [No Abstract]   [Full Text] [Related]  

  • 34. Decorporation of inhaled americium-241 dioxide and nitrate from hamsters using ZnDTPA and Puchel.
    Stradling GN; Stather JW; Sumner SA; Moody JC; Strong JC
    Health Phys; 1984 Jun; 46(6):1296-300. PubMed ID: 6724941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acceleration in the elimination of yttrium 91, lanthanum 140, cerium 141, praseodymium 143, neodymium 147 and promethium 147].
    Koval' IuF; Kondrashev VM
    Med Radiol (Mosk); 1967 Mar; 12(3):84-5. PubMed ID: 4982283
    [No Abstract]   [Full Text] [Related]  

  • 36. Importance of initial management of persons internally contaminated with radionuclides.
    Lincoln TA
    Am Ind Hyg Assoc J; 1976 Jan; 37(1):16-21. PubMed ID: 1246944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical response to radiation-related terrorism.
    Yu CE
    Pediatr Ann; 2003 Mar; 32(3):169-76. PubMed ID: 12661491
    [No Abstract]   [Full Text] [Related]  

  • 38. Chelation therapy for the treatment of thalassemia.
    Graziano JH; Cerami A
    Semin Hematol; 1977 Jan; 14(1):127-34. PubMed ID: 318766
    [No Abstract]   [Full Text] [Related]  

  • 39. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivation and validation of a urinary excretion function for plutonium based on occupational exposure.
    Yadav JR; Rao DD; Hegde AG; Aggarwal SK
    Radiat Prot Dosimetry; 2008; 129(4):386-90. PubMed ID: 17974581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.